Bruker
High-performance scientific instruments and high-value analytical and diagnostic solutions.
Launch date
Employees
Market cap
$9.8b
Enterprise valuation
$11.9b (Public information from Sep 2024)
Share price
$66.8 BRKR
Billerica Massachusetts (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 2.0b | 2.4b | 2.5b | 3.0b | 3.4b | 3.7b | 4.0b |
| % growth | (4 %) | 22 % | 5 % | 17 % | 15 % | 9 % | 7 % |
| EBITDA | 354m | 517m | 550m | 604m | 635m | 747m | 849m |
| % EBITDA margin | 18 % | 21 % | 22 % | 20 % | 19 % | 20 % | 21 % |
| Profit | 158m | 277m | 297m | 427m | 256m | 382m | 571m |
| % profit margin | 8 % | 11 % | 12 % | 14 % | 8 % | 10 % | 14 % |
| EV / revenue | 4.2x | 5.4x | 4.2x | 3.7x | 3.5x | 3.1x | 2.8x |
| EV / EBITDA | 23.8x | 25.1x | 19.3x | 18.1x | 18.9x | 15.2x | 13.2x |
| R&D budget | 198m | 221m | 236m | 295m | - | - | - |
| R&D % of revenue | 10 % | 9 % | 9 % | 10 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
$22.5m | Post IPO Equity | ||
| N/A | N/A | Post IPO Debt | |
* | N/A | N/A | Post IPO Equity |
| Total Funding | - | ||
Recent News about Bruker
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
By Industry
Investments by Bruker
Edit
ACQUISITION by Bruker Jan 2023
ACQUISITION by Bruker Oct 2015
ACQUISITION by Bruker Nov 2022
ACQUISITION by Bruker Sep 2013
ACQUISITION by Bruker Apr 2024
ACQUISITION by Bruker Mar 2019
ACQUISITION by Bruker Dec 2023
ACQUISITION by Bruker Nov 2021
ACQUISITION by Bruker May 2017